Marion Dorsch is CSO at Blueprint Medicines Corp (BPMC). They have made 13 open-market trades across 1 company since 2017, most recently 2021-02-22.
CIK 0001690460
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BPMC | 22,828 | $3.0M |
Shares reported on the most recent Form 4, priced at the 2021-02-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPMC | SELL | 2021-02-22 | 2021-02-24 | $100.00 | $758K | -5.8% | -1.1% | -2.4% |
| BPMC | SELL | 2020-12-14 | 2020-12-16 | $119.00 | $547K | -0.6% | -14.0% | -11.8% |
| BPMC | SELL | 2020-10-06 | 2020-10-08 | $99.00 | $455K | +2.7% | -0.6% | +5.0% |
| BPMC | SELL | 2020-09-23 | 2020-09-25 | $89.00 | $409K | +12.5% | +16.8% | +39.3% |
| BPMC | SELL | 2020-06-19 | 2020-06-23 | $79.00 | $363K | +1.7% | -2.6% | -0.8% |
| BPMC | SELL · 10b5-1 | 2020-03-23 | 2020-03-25 | $52.49 | $64K | +15.3% | +24.1% | +38.6% |
| BPMC | SELL | 2020-03-09 | 2020-03-11 | $51.99 | $28K | +6.0% | +32.0% | +51.7% |
| BPMC | SELL | 2019-12-19 | 2019-12-23 | $79.00 | $363K | -0.9% | -14.9% | -37.4% |
| BPMC | SELL | 2019-06-17 | 2019-06-19 | $99.00 | $455K | -1.1% | -0.3% | -17.4% |
| BPMC | SELL | 2019-03-04 | 2019-03-06 | $84.66 | $195K | +5.2% | +5.9% | -0.1% |
| BPMC | SELL | 2018-09-17 | 2018-09-19 | $70.47 | $162K | +2.3% | -6.0% | -22.6% |
| BPMC | SELL | 2018-03-15 | 2018-03-19 | $100.07 | $460K | -8.3% | -13.2% | -32.2% |
| BPMC | SELL | 2017-11-22 | 2017-11-24 | $70.00 | $642K | -4.6% | +6.9% | +22.3% |
| BPMC | SELL | 2017-11-21 | 2017-11-22 | $65.48 | $2.3M | -4.7% | +11.5% | +16.3% |
| BPMC | SELL · 10b5-1 | 2017-11-21 | 2017-11-24 | $64.44 | $32K | -4.6% | +6.9% | +22.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.